Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study

• Main Authors: Rubén Martín-Escolano (Author), Ana Virseda-Berdices (Author), Juan Berenguer (Author), Juan González-García (Author), Oscar Brochado-Kith (Author), Amanda Fernández-Rodríguez (Author), Cristina Díez (Author), Victor Hontañon (Author), The Marathon Study Group (Author), Salvador Resino (Author), María Ángeles Jiménez-Sousa (Author), A. Arranz (Author), F. Arnalich (Author), J. R. Arribas (Author), E. Aznar (Author), T. Aldamiz-Echevarría (Author), J. Bermejo (Author), J. Berenguer (Author), J. M. Bellón (Author), I. Bernardino (Author), M. J. Bustinduy (Author), A. Carrero (Author), S. Carretero (Author), E. Casas (Author), J. L. Casado (Author), M. Crespo (Author), P. Crespo (Author), C. Díez (Author), M. Díaz (Author), J. de Miguel (Author), F. Dronda (Author), H. Esteban (Author), C. Fanciulli (Author), A. Ferrer (Author), M. J. Galindo (Author), J. González-García (Author), I. Gutiérrez (Author), . A. Iribarren (Author), V. Hontañón (Author), C. López (Author), P. Miralles (Author), M. L. Montes (Author), A. Moreno (Author), S. Moreno (Author), L. Ortiz (Author), E. Ortega (Author), B Padilla (Author), J. F. Parras (Author), L. Pérez-Latorre (Author), F. Pascual (Author), M. Pérez (Author), M. J. Pérez-Elías (Author), J. M. Peña (Author), C. Quereda (Author), M. Ramírez (Author), E. Ribera (Author), J. F. Rodríguez-Arrondo (Author), J. Sanz (Author), I. Santos (Author), M. A. Sanfrutos (Author), S. Schroeder (Author), F. Tejerina (Author), M. J. Téllez (Author), E. Van den Eynde (Author), J. Vergas (Author), M. A. Von-Wichmann (Author), M. Yllescas (Author), J. F. Zamora (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundUnderstanding the predictors of metabolic disorders in persons with HIV/HCV coinfection post-HCV therapy is crucial for improving patient outcomes. Since immune checkpoint proteins are usually upregulated in these persons with HIV/HCV coinfection, we aimed to evaluate the association betwe...